PT-141
PT-141
Research Use Only and not for human consumption. Bionk Peptides delivers high-performance research compounds engineered with uncompromising attention to detail. Every vial is produced to exceed 99% purity and supplied in lyophilised powder form, preserving molecular integrity while ensuring optimal stability and precision in application. Bionk Peptides are commitment to elevated research performance.
Couldn't load pickup availability
Description
PT-141
Bremelanotide (PT-141) is a synthetic peptide used to treat sexual dysfunction, including hypoactive sexual desire disorder (HSDD) in women and erectile dysfunction (ED) in men. It acts on the central nervous system to increase sexual desire, arousal, and satisfaction, often proving effective when blood-flow-based treatments like Viagra fail.
- Increased Sexual Desire/Libido:
Unlike PDE5 inhibitors (e.g., Cialis) that focus on blood flow, PT-141 acts on the brain's melanocortin receptors (MC4R) to increase desire and libido directly. - Treatment for Female Sexual Dysfunction:
FDA-approved to treat acquired, generalized HSDD in premenopausal women. -
Effective for ED in Men:
Can assist with erectile dysfunction, especially cases linked to psychological factors or low desire. -
Rapid Onset:
Effects are often felt within 30 to 60 minutes after administration, with potential benefits lasting up to 72 hours. -
Versatile Administration:
Available as a subcutaneous injection (common) or intranasal spray. - Improved Sexual Satisfaction:
- Many users report improved libido, sexual arousal, and better overall sexual experience.
